A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD)

Clinical trial NCT00890292 · COMPLETED

Trial details

NCT number: NCT00890292
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder Attention Deficit Disorders With Hyperactivity

Start date: 2009-05-01
Primary completion: 2009-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.